Cutler Group LP Syros Pharmaceuticals, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$7.14 - $11.65 $13,566 - $22,135	-1,900 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$5.5 - $9.75 $550 - $975	-100 Reduced 5.0%	1,900 $17,000
Q1 2019 May 10, 2019	SELL	$5.51 - $9.59 $12,122 - $21,098	-2,200 Reduced 52.38%	2,000 $18,000
Q4 2018 Feb 05, 2019	BUY	$5.55 - $11.34 $22,200 - $45,360	4,000 Added 2000.0%	4,200 $23,000
Q3 2018 Nov 07, 2018	SELL	$9.74 - $12.92 $1,948 - $2,584	-200 Reduced 50.0%	200 $2,000
Q2 2018 Aug 10, 2018	BUY	$10.16 - $13.65 $3,048 - $4,095	300 Added 300.0%	400 $4,000
Q1 2018 May 11, 2018	SELL	$9.47 - $12.98 $77,654 - $106,436	-8,200 Reduced 98.8%	100 $1,000
Q4 2017 Jan 17, 2018	BUY	$8.45 - $17.48 $70,135 - $145,084	8,300	8,300 $80,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $5.87M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.